SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-20-000011
Filing Date
2020-02-24
Accepted
2020-02-24 16:07:15
Documents
16
Period of Report
2020-02-24
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq42019.htm   iXBRL 8-K 48360
2 EXHIBIT 99.1 ex991q420198-k.htm EX-99.1 169525
8 halozymea13.jpg GRAPHIC 701236
  Complete submission text file 0001159036-20-000011.txt   1317579

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20200224.xsd EX-101.SCH 4582
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20200224_cal.xml EX-101.CAL 620
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20200224_def.xml EX-101.DEF 1470
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20200224_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20200224_pre.xml EX-101.PRE 13576
11 EXTRACTED XBRL INSTANCE DOCUMENT a8-kq42019_htm.xml XML 4562
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 20644345
SIC: 2836 Biological Products, (No Diagnostic Substances)